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Abstract
Background:  Inappropriate antibiotic use is a global public health problem with serious consequences,
including antimicrobial resistance.  In response, countries have to take comprehensive action with
interventions that improve antibiotic use at various levels.   Several reviews have evaluated interventions
on antibiotic prescribing practices in different healthcare settings.
Objective:  To identify interventions targeting antibiotic prescribing by medical doctors in primary health
care in upper middle-income countries and to assess intervention effectiveness.
Methods:  We undertook systematic literature review of studies for the period 1990 – 2009.  Studies had
to report quantitative data on antibiotic prescribing by primary care doctors using medicines use
indicators.  Intervention effects were based on data from intervention studies with valid study designs.
Results:  Eight studies describing ten interventions met all the inclusion criteria.  We found that single
educational interventions targeting all diseases had low or no impact on percentages of patients
prescribed antibiotics.  Greater impact on antibiotic prescribing was achieved by multifaceted interventions
focusing on specific diseases.
Conclusion:   The limited evidence on interventions from upper middle-income countries has produced
results similar to other reviews.  More concerted commitment is needed to monitor antibiotic prescribing
regularly and to conduct well designed evaluations of interventions.
Introduction
Since the introduction of penicillin in the 1940s,
antibiotics have been essential for the treatment of many
bacterial infections. Meanwhile, antibiotics have become
subject to many overuse and misuse prescribing
practices.  They have been unnecessarily prescribed for
viral infections, against which they have no effect [1,2].
Similarly, when diagnoses had not been accurately
made, broad-spectrum antibiotics have been prescribed
because the causative micro-organism has been
unknown [1].  Widespread irrational patterns include
antibiotic use in acute diarrhoea or in upper respiratory
tract infections (URTI) with predominantly viral aetiology
[3-12].
A World Health Organization (WHO) review has
shown increase in antibiotic use over the last 20 years in
developing and transitional countries, reaching 50% of
prescriptions in primary health care.  Half of antibiotics
were prescribed inappropriately or in underdosage.  Over
two-thirds of all URTI cases received antibiotics
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unnecessarily, while less than 80% of pneumonia cases
were treated with appropriate antibiotics [3].  Data from
the European Surveillance of Antibiotic Consumption
demonstrated large variations in outpatient antibiotic
consumption across 25 European countries [11].
Antibiotic overprescribing has been demonstrated even
in European countries with lower rates of antibiotic use,
such as the Netherlands [12].
Inappropriate antibiotic use entails an increased
risk of side effects, high costs, and accelerated
emergence, selection and spread of resistant bacteria
[11,13-15].  Microorganisms become resistant to
affordable and effective first-line antibiotics, which leads
to inadequate treatment of the infection [1, 2, 16].
Unfortunately, while resistance to older antibiotics is
increasing, development of new generations of antibiotics
is not promising [17].
Therefore, growing antimicrobial resistance
associated with inappropriate antibiotic use is of great
public health concern globally [3,12,18,19].  In response,
numerous policies and guidelines promoting appropriate
use of available antibiotics have been introduced
internationally [20-27].  However, combating
inappropriate use of medicines requires comprehensive
action with interventions that improve medicines use at
different levels [28-31].
Several systematic reviews have summarized
effects of different types of interventions targeting health
providers’ prescribing practices. Published studies have
focused on different aspects on medicines use, various
diseases and health care settings in both developed and
developing countries [3, 29, 32-35].  Despite diversity,
their results showed similar findings.  Most interventions
have been educational in nature, but multi-faceted
interventions, involving educational and managerial
components, have been more effective than those
employing only one strategy [3, 29, 32-35].
Our research focused on antibiotic prescribing
interventions in upper middle-income countries (UMICs).
This particular income group is selected to represent
settings comparable to the Republic of Macedonia,
classified as UMIC by the World Bank [36].  Our review
is expected to inform future national strategies on
appropriate antibiotic use in the Republic of Macedonia.
This research aims to: (1) undertake literature
review to identify interventions targeting antibiotic
prescribing by medical doctors in primary health care in
UMICs, (2) describe intervention studies with valid study
designs, and (3) assess intervention effectiveness.
Methodology
Search strategy and criteria
The systematic search was conducted using
published articles and unpublished reports for the period
1990 – 2009.  The sources included: the International
Network for the Rational Use of Drugs (INRUD)
Bibliography on medicines use [37], Embase, PubMed,
World Health Organization (WHO) and international
agencies’ archives on medicines programmes, primary
care and child health.  Study inclusion criteria were: an
‘intervention’ aiming to ‘improve antibiotic prescribing
practices’ by ‘medical doctors’ conducted in a ‘primary
care’ setting in an ‘upper middle-income country’.  Studies
had to report quantitative data on antibiotic prescribing
by primary care doctors using medicines use indicators.
According to the World Bank (WB) 2010 classification,
UMICs had Gross National Income (GNI) per capita in
the range $3,976 - $12,275, and included 54 countries
from 6 regions in 2010 [36].
Criteria for methodological adequacy
Only intervention studies using randomized
control trials (RCT), pre-post measurements with a
control group (PP&C), and interrupted time series with or
without a comparison group (TS&C, TS-C) were
considered to have valid study designs.
Other key aspects of methodological quality
taken into consideration were the overall patients sample
size and the number of healthcare facilities included in
the intervention surveys.  Studies involving less than 100
cases or 5 health facilities were excluded from the
review.
Classification of interventions
The commonly used interventions were broken
down into the following categories and subcategories,
described below:  [3, 28-31]
1. Provider education (Formal education,
Seminars and trainings, Academic detailing);
2. Printed materials (Formulary lists, Treatment
guidelines, Newspapers and bulletins);
3. Consumer education (Media - TV and radio,
Printed material, Home visits);
4. Managerial strategies (Clinical supervision
systems, Audit and/or feedback, Drug utilization review,
Drug Therapeutic Committees);
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5. Community Case Management (Training/
supervision of community members to provide treatment
for certain diseases, Medicines supply to trained
layperson);
6. Group process strategies (Review, Drug
Therapeutic Committees, Management, training and
planning activities);
7. Regulatory interventions (Professional
licensing, Registration, Practice laws);
8. Economic strategies (Prescription fee and
consultation fee, fee per drug item, Revolving drug fund,
Health insurance);
9. Essential Medicines Programme (Essential
drugs list, Structured prescribing forms, Generic
substitution, Prior authorization, Medicines supply).
Measuring study effects and effect size
Main outcome measures used to assess
changes in antibiotic use were changes in medical
doctors’ antibiotic prescribing.  The antibiotic outcomes
included certain WHO/INRUD indicators [38] and WHO
IMCI indicators [39], but excluded DDD measures and
patients’ adherence indicators.  The antibiotic prescribing
outcomes (prescribing indicators) were as follows:  (1)
Percentage of patients prescribed antibiotics, (2)
Percentage of viral upper respiratory tract infections
(URTI) treated with antibiotics, (3) Percentage of
pneumonia cases treated with appropriate antibiotics.
The intervention effects were based on data
from intervention studies with valid study designs.  The
method that summarised interventions’ effects compared
improvement in each antibiotic use outcome as reported
by individual authors.   In all cases other than for
pneumonia, the desired improvement was a reduction in
use.   However, for pneumonia, the goal was to increase
the use of appropriate antibiotics in patients suspected
of having the disease.  The effect sizes for all outcome
measures were calculated as follows:
Effect Size = (%Post-% Pre) Intervention
(%Post-% Pre) Control
When intervention studies reported multiple post-
intervention assessments, the last post-intervention data
point was used to calculate study effects.  For time series
with no control, the effect size was the net difference
between the last post intervention value and the pre
intervention value.
Large impact was defined as more than 30 %
improvement, moderate impact as 10–30 % of
improvement, and low or no impact as less than 10 % of
improvement in a targeted outcome relative to control.
Where available, we accompanied our
calculated effect sizes by information on results’ variability
and statistical significance, as stated in the original
papers.  Original details on confidence intervals or p-
values were intended to show results strength and
precision, and demonstrate the quality of corresponding
studies.
Data extraction
Data were extracted using designed data
extraction sheet with following information: (1) Literature
source, (2) Demographic details (country, years of
measurement, health care setting and ownership, patient
age, target disease), (3) Methodological details (study
design, number of facilities and cases), (4) Intervention
components and types, and (5) Outcome antibiotic
measures (indicator types) and intervention effect sizes.
Results
Literature review outcome
We initially screened 60 potential studies from
22 UMICs that included interventions on antibiotic
prescribing in primary health care.  However, only 12
studies had valid study designs according to our
methodological criteria.  Additionally, four studies were
excluded because they reported antibiotic prescribing
by health workers other than medical doctors, such as
paramedical workers, nurses, pharmacists and trained
lay persons.  Finally, eight studies (describing ten
interventions) met all the inclusion criteria and were
included in the review [40-47].
Description of intervention studies
Seven studies were retrieved from published articles,
while only one was an unpublished report from WHO
archives.  Studies were distributed over three World
Bank geographical regions: East Asia and Pacific (China
and Malaysia), Middle East and North Africa (Iran) and
Latin America (Cuba, Mexico and Ecuador).  No studies
with valid design were identified from Europe/Central
Asia and Sub-Saharan Africa.
Six studies were carried out after year 2000, and
two in the early 1990s.  Six surveys were conducted in
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public primary health care centres (PHC), and only two
in outpatient departments within public hospitals.  No
study with valid study design has been conducted in the
private sector.  Half of the interventions targeted one
specific health condition: acute respiratory illness (ARI),
while the rest included all illnesses from primary
healthcare settings.  Six studies analysed patients of all
ages, and two included only children under 5 years old.
In terms of methodology employed, one study
was a randomized controlled trial, and seven studies
were pre-post-measurements with a comparison group.
Table 1 gives a comprehensive summary of all reviewed
studies and their references, including demographic
and methodological study characteristics and intervention
types.
Intervention types
In total, ten interventions of six types were
employed to optimise antibiotic prescriptions by medical
doctors.  Five of them were single-component, and five
were multi-components.  The interventions were as
follows:
1. Provider education (4 studies);
2. Consumer education (1 study);
3. Provider education and supervision (1 study);
4. Provider education with group process
strategies – peer review committee (1 study) and
pharmacy committee (1 study);
5. Provider and consumer education with
supervision (1 study); and
6. Multifaceted intervention consisting of
educational, economic, and essential drug list strategies
(1 study).
All of the interventions involved educational
components and half of them consisted of only one
educational component (provider or consumer
education). The other half involved educational
interventions combined with managerial ones.
Intervention effectiveness
Table 2 gives details of the intervention
components, study outcomes, statistical significance of
the results in the original studies, and calculated effect
sizes.
Table 3 summarizes the intervention impact on
antibiotic indicator values in descending order by the
degree of effect.
The positive sign (+) illustrates positive
intervention impacts, such as reduced antibiotic use in
all patients, reduced antibiotic use for viral upper
respiratory tract infection and increased antibiotic use
for pneumonia.  For the indicators “% viral upper
respiratory tract infections treated with antibiotics” and
“% patients treated with antibiotics”, where reduced use
is better use, the sign of the calculated result in Table 3
has been changed, so that its positive sign is associated
with an increased use of appropriate antibiotics.
All original studies (except #43) included
statistical hypothesis testing with 0.05 or 0.001 level of
significance, while none constructed confidence intervals
around the results.  As illustrated in Table 2, significant
differences between intervention and control groups
had been reported in the studies where we calculated at
least 8% improvement.
We found out that the indicator “percentage of
Table 1: Description of included interventions.
PHC - Primary Healthcare Centre,  ARI – Acute Respiratory Infection, MD – Medical Doctors,
PP&C - Pre-post with control group, RCT - Randomized control trial, TS-C – Time series
without control group, EML – Essential Medicines List.
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patients prescribed antibiotics” was reduced only by
multifaceted interventions focusing on specific diseases
(Table 3).  For instance, the intervention in study #47
targeted ARI using multiple strategies (peer review
committees), and reduced the indicator by 21.5%.  By
contrast, interventions with no focus on specific diseases
(studies # 40, 43-46) achieved low or no impact on this
indicator (-1.7% to 4.1%).  Four of them included only
educational interventions (studies #43-46), while the
intervention in study #40 was multifaceted.  However,
even the multifaceted intervention did not reduce the
indicator (-2.5%), as it did not target any specific disease.
Similarly, the indicator “percentage of URTI
treated with antibiotics” was reduced only by multifaceted
interventions targeting specific diseases (Table 3).
Interventions that combined educational and managerial
interventions in the studies #46 (academic detailing) and
#47 (interactive educational workshop with peer review
Table 2:  Effectiveness of the included interventions.
Table 3: Summary of the interventions and their effect size.
AB - Antibiotics, ARI – Acute Respiratory Infection, URTI –Upper Respiratory Tract Infection,
PHC - Primary Healthcare Centre,  MD – Medical Doctors, EML – Essential Medicines List,
STG – Standard Treatment Guidelines, CME – Continuing Medical  Education. *-For the
intervention impact, improved antibiotic use is reflected by reduced antibiotic use in general
and for URTI (negative value) and increased antibiotic use in pneumonia (positive value). **
- Information extracted from the original studies.
* - Intervention effects are expressed positively in comparison with Table 1 where the actual
values of effectiveness are expressed.  Thus, a decrease (negative value) in antibiotic use in
general and for URTI and an increase in antibiotic use for pneumonia represents improved
(positive value) use. ** - Statistically significant in original studies. *** - Statistically significant
difference between control and intervention groups after the intervention in original studies.
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committees) focusing on ARI, reduced the indicator by
8.6% and 17.6% respectively.  Likewise, study #41
examined the impact of three different interventions on
the indicator “percentage of URTI treated with antibiotics”.
First, the single ‘Consumer education’ intervention did
not reduce the indicator (-0.2%).  Second, the multifaceted
intervention consisting of ‘Provider education’, ‘Printed
materials’ and ‘Managerial strategy’ (refresher training
course, group discussion of guidelines, follow-up session,
and advisory visits) had an impact of 9.6%.  When
‘Consumer education’ was added to the latter
combination, the overall impact increased to 19.5%.
Lastly, we investigated the intervention
effectiveness on the indicator “appropriate antibiotic
prescribing in pneumonia”, However, it was difficult to
draw any conclusions as the indicator was used only in
study #42.  This intervention targeted a specific disease
(ARI) and used combined intervention strategies.  Both
control and the intervention groups had high baseline
rates and achieved low impact effect (5%), which was
reported as statistically not significant.
Discussion
We identified only eight studies of acceptable
quality that evaluated interventions for improving antibiotic
prescribing in 54 UMICs over a period of 20 years.  This
small body of evidence may not be sufficient to provide
comprehensive knowledge on the subject. However,
some conclusions can still be drawn about effectiveness
of different strategies.
It is important to note that the particular group of
UMICs was selected in order to learn about health
interventions applicable to the Republic of Macedonia.
However, WB classification by income level does not
imply that countries in the same group experience similar
health care system development [36].  To overcome
some of the context diversity, search criteria included
only interventions that affected the prescribing by a
homogenous group of medical doctors.  It is disappointing
that no valid study has been detected from Eastern
Europe (WB region of Europe/Central Asia) because of
the healthcare setting similarity with the Republic of
Macedonia [49].  As the country is European Union
candidate, it is recommended to expand future research
by including European high-income countries.
Our results show that interventions were
predominantly educational in nature, and conducted
only in the public sector.  In general, the intervention
effects were similar to findings from other systematic
reviews on antibiotic use in developed and developing
countries [32, 34, 35].  Results suggest that interventions
with low or no impact on antibiotic prescribing employ
only educational components with no specific disease
focus.  Multi-faceted interventions, involving educational
and managerial components, such as education for both
medical doctors and patients combined with advisory
visits or peer review committees improved the antibiotic
prescribing in primary healthcare.   Similarly, interventions
focusing only on specific diseases have great potential
for improving antibiotic prescribing practices.
In order to develop targeted intervention
strategies, it is essential to generate more reliable data
through research.  Particular areas that need further
improvement include: conducting   more well designed
evaluations of interventions, increasing the reporting
quality of the results by adding their significance and
degree of variability, and publishing study findings.
Conclusions: The issue of inappropriate use of
antibiotics is of global concern, because of its association
with increased antibiotic resistance.  Various interventions
have been carried out with the aim of improving antibiotic
prescribing practice.  This review has shown that only
limited evidence with acceptable quality on interventions
evaluation in UMICs exists. While our results emphasize
the important role of multifaceted interventions in the
public sector, much still remains unexplored about
practices in the private sector.   Countries and international
organizations need to be more committed to monitor
antibiotic prescribing regularly and to conduct well
designed evaluations of interventions.
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